Yuanyuan Wen

Yuanyuan Wen

Auto-generated profile, based on publicly available information

Yuanyuan Wen

Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Nanjing 210009, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2019 in Nanoscale
Verified
Journal Article
Closed access
PDF file
YWYuanyuan Wen
Yuanyuan Wen
YLYuxiao Liu
Yuxiao Liu
HZHan Zhang
Han Zhang
MZMinhan Zou
Minhan Zou
DYDan Yan
Dan Yan
YZYuanjin Zhao
Yuanjin Zhao
The relatively higher temperature of the tumor site and the temperature responsive shape transition of pNIPAM hydrogel make the controllable drug release possible for oncotherapy.

30 December 2020 in Biomaterials Science
Verified
Journal Article
Closed access
PDF file
YWYuanyuan Wen
Yuanyuan Wen
YLYuxiao Liu
Yuxiao Liu
CCCanwen Chen
Canwen Chen
JCJunjie Chi
Junjie Chi
LZLiping Zhong
Liping Zhong
YZYuanjin Zhao
Yuanjin Zhao
PD1/PD-L1 antibody blockade-based immunotherapy has been widely recognized in the field of cancer treatment; however, only a small number of cancer patients have been shown to respond well due to the PD1/PD-L1 antibody hydrolysis induced substandard immunotherapeutic efficacy and the low immunogenicity and immunosuppressive tumor microenvironment of the patients. Here, we present a novel tumor microenvironment (TME) responsive particle delivery system with a metformin-loaded chitosan (CS) inverse opal core and a manganese dioxide (MnO2) shell (denoted as CS-metformin@MnO2 particles) for inhibiting the PD-1/PD-L1 signaling pathway and promoting tumor immunotherapy. Benefiting from the interconnected porous structure of the inverse opal, metformin can be easily extensively loaded into the CS particles. With the coating of the TME responsive MnO2 shells, the particle delivery system was imparted with an intelligent “trigger” to prevent premature leaking of the drug until it reaches the tumor tissue. We have demonstrated that CS-metformin@MnO2 particles were able to promote the apoptosis of tumor cells through immunotherapeutic means both in vivo and in vitro. Specifically, the viability of tumor cells in the drug carrier-treated group was nearly 20% less than in the untreated group. In addition, the CS particles could serve as scaffolds for the regeneration of normal tissues and promote post-surgical wound healing due to their biocompatibility and antibacterial ability. These results make CS-metformin@MnO2 particles an excellent delivery system in tumor immunotherapy and post-surgical wound healing applications.

10 April 2024 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
YWYuanyuan Wen
Yuanyuan Wen
KLKaiming Li
Kaiming Li
MNMengnan Ni
Mengnan Ni
HJHui Jiang
Hui Jiang
HWHaisi Wu
Haisi Wu
HXHuae Xu
Huae Xu

12 October 2023 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
HJHui Jiang
Hui Jiang
CTChunming Tang
Chunming Tang
YWYuanyuan Wen
Yuanyuan Wen
QZQianqian Zhao
Qianqian Zhao
MXMingyuan Xu
Mingyuan Xu
GCGang Chen
Gang Chen

1 January 2019 in Ecological Indicators
Verified
Journal Article
Closed access
YWYuanyuan Wen
Yuanyuan Wen
HLHongtao Li
Hongtao Li
XDXuan Du
Xuan Du
KYKaijun Yang
Kaijun Yang
Marco CasazzaMarco Casazza
Marco Casazza
GLGengyuan Liu
Gengyuan Liu

12 December 2021 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
YZYalan Zhang
Yalan Zhang
YWYu Wang
Yu Wang
YWYuanyuan Wen
Yuanyuan Wen
QZQifeng Zhong
Qifeng Zhong
YZYuanjin Zhao
Yuanjin Zhao